不同分次剂量同步整合加量调强放疗对局部晚期非小细胞肺癌局部区域控制的探究:临床结局与扩展LQ/TCP模型应用
分次剂量是LPFS的独立预后因素,A、B、C组中位LPFS分别为13.8、35.7个月和未达到。新LQRG/TCP模型预测LPFS的拟合误差优于传统LQ/TCP模型。
要点
- 分次剂量是局部晚期非小细胞肺癌同步放化疗后LPFS的独立预后因素。
- 分次剂量2.5–3.1 Gy组中位LPFS未达到,优于2.2–2.5 Gy组和2.0–2.2 Gy组。
- 新LQRG/TCP模型预测LPFS的拟合误差低于传统LQ/TCP模型。
核心结论
- 大分割调强放疗可作为局部晚期非小细胞肺癌剂量强化的有效方法。
- 与经典LQ模型相比,LQRG模型在预测随访时间依赖的LPFS方面表现更优。
研究设计与样本
- 按分次剂量三分位分为A组(2.0≤分次剂量<2.2 Gy)、B组(2.2≤分次剂量<2.5 Gy)、C组(2.5≤分次剂量≤3.1 Gy)。
- 采用单因素和多因素分析评估LPFS的预测因素,并开发结合放射生物学四个「R」和Gompertzian肿瘤生长的LQRG/TCP模型预测LPFS。
主要发现
- 中位随访22.1个月,中位LPFS为23.8个月。
- 分次剂量是LPFS的独立预后因素。
- A、B、C组中位LPFS分别为13.8、35.7个月和未达到。
- LQRG/TCP模型预测LPFS的平均绝对拟合误差和相对拟合误差:A组6.9和19.6%,B组5.5和8.8%,C组6.6和9.5%。
- 传统LQ/TCP模型预测LPFS的平均绝对拟合误差和相对拟合误差:A组9.5和29.4%,B组16.6和36.7%,C组24.8和39.1%。
关键数值与推荐
- 分次剂量分组标准:A组2.0≤分次剂量<2.2 Gy,B组2.2≤分次剂量<2.5 Gy,C组2.5≤分次剂量≤3.1 Gy。
- LQRG/TCP模型拟合误差低于传统LQ/TCP模型。
临床怎么用
- 对于局部晚期非小细胞肺癌,可考虑采用大分割调强放疗进行剂量强化。
- LQRG/TCP模型可用于预测随访时间依赖的LPFS,辅助临床决策。
局限性
- 回顾性分析,样本量有限。
- 需进一步前瞻性研究验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: To investigate the loco-regional progression-free survival (LPFS) of intensity-modulated radiotherapy (IMRT) with different fraction sizes for locally advanced non-small-cell lung cancer (LANSCLC), and to apply a new radiobiological model for tumor control probability (TCP). METHODS: One hundred and three LANSCLC patients treated with concurrent radiochemotherapy were retrospectively analyzed. Factors potentially predictive of LPFS were assessed in the univariate and multivariate analysis. Patients were divided into group A (2.0 ≤ fraction size<2.2Gy), B (2.2 ≤ fraction size<2.5Gy), and C (2.5 ≤ fraction size≤3.1Gy) according to the tertiles of fraction size. A novel LQRG/TCP model, incorporating four "R"s of radiobiology and Gompertzian tumor growth, was developed to predict LPFS and compared with the classical LQ/TCP model. RESULTS: With a median follow-up of 22.1 months, the median LPFS was 23.8 months. Fraction size was independently prognostic of LPFS. The median LPFS of group A, B and C was 13.8, 35.7 months and not reached, respectively. Using the new LQRG/TCP model, the average absolute and relative fitting errors for LPFS were 6.9 and 19.6% for group A, 5.5 and 8.8% for group B, 6.6 and 9.5% for group C, compared with 9.5 and 29.4% for group A, 16.6 and 36.7% for group B, 24.8 and 39.1% for group C using the conventional LQ/TCP model. CONCLUSIONS: Hypo-fractionated IMRT could be an effective approach for dose intensification in LANSCLC. Compared with conventional LQ model, the LQRG model showed a better performance in predicting follow-up time dependent LPFS.
引用
- Qiu B, Li QW, Ai XL, et al. Investigating the loco-regional control of simultaneous integrated boost intensity-modulated radiotherapy with different radiation fraction sizes for locally advanced non-small-cell lung cancer: clinical outcomes and the application of an extended LQ/TCP model. Radiat Oncol. 2020. PMID: 32460796. doi:10.1186/s13014-020-01555-x
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。